Summary
Overexpression of a Mr 170,000 membrane glycoprotein (P-glycoprotein) is consistently associated with multidrug resistance in cell lines. Two monoclonal antibodies (Mab) against P-glycoprotein (265/F4 and C 219) were used to examine tumour samples from patients with leukemias for evidence of P-glycoprotein overexpression. High levels of P-glycoprotein (>5% positive cells) were detected with both antibodies in samples from 3 out of 18 patients suggesting that a multidrug resistant phenotype may also occur in human leukemias.
References
Bell DR, Gerlach JH, Kartner N, Buick RN, Ling V (1985) Detection of P-glycoprotein in ovarian cancer: A molecular marker associated with multidrug resistance. J Clin Oncol 3: 311–315
Biedler JL, Chang T, Meyers MB, Peterson RHF, Sprengler BA (1983) Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 67: 859–867
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152–162
Kartner N, Evernden-Porelle D, Bradley G, Ling V (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316: 820–823
Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein associated with multidrug-resistance in mammalian cell lines. Science 221: 1285–1288
Lathan B, Edwards DP, Dressler LG, Von Hoff DD, McGuire WL (1985) Immunological detection of Chinese hamster ovary cells expressing a multidrug resistance phenotype. Cancer Res 45: 5064–5069
Ma DDF, Davey RA, Harman DH, Isbister JP, Scurr RD, Mackertich SM, Dowden G, Bell DR (1987) Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukemia. The Lancet I: 135–137
Mattern J, Volm M (1982) Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev 9: 267–298
Riordan JR, Ling V (1985) Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther 28: 51–75
Skovsgaard T (1978) Mechanisms of resistance to daunomycin in Ehrlich Ascites tumor cells. Cancer Res 38: 1785–1791
Tsuruo I, Sugimoto Y, Hamada H, Roninson I, Okumura M, Adachi K, Morishima Y, Ohno R (1987) Detection of multidrug resistance markers, P-glycoprotein and mdr 1 mRNA in human leukemia cells. Jpn J Cancer Res (Gann) 78: 1415–1419
Volm M, Bak M, Efferth T, Mattern J (1988) Induced multidrug resistance in murine leukemia L 1210 and associated changes in a surface membrane glycoprotein. J Cancer Res Clin Oncol (in press)
Volm M, Bak M, Efferth T, Lathan B, Mattern J (1988) Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res 8: 531–536
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mattern, J., Efferth, T., Bak, M. et al. Detection of P-glycoprotein in human leukemias using monoclonal antibodies. Blut 58, 215–217 (1989). https://doi.org/10.1007/BF00320777
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320777